Tejnaksh Healthcare informs about disclosure

23 Oct 2023 Evaluate
Tejnaksh Healthcare has informed that Mumbai, India - The West Zone Urological Society, comprising Maharashtra, Gujarat, Madhya Pradesh, Goa, and Chhattisgarh, proudly announces the election of Dr. Ashish Rawandale, Managing Director of our Company as its President for the term 2024-2025. This significant decision reflects the collective trust and unwavering support of the society members, acknowledging Ashish's unparalleled dedication to advancing urological healthcare and fostering innovation within the region. In response to this prestigious appointment, Ashish expressed his profound gratitude, emphasizing his commitment to delivering impactful and progressive initiatives during his upcoming term. The anticipation within the urological community is palpable a Ashish's leadership is poised to usher in a promising era of growth and development for the West Zone Urological Society. Notably, Tejnaksh Healthcare Limited has played a pioneering role in urology treatments and innovations, providing crucial support and resources to further enhance the field. The West Zone Urological Society recognizes the invaluable contribution of Tejnaksh Healthcare and looks forward to continued collaboration for the betterment of urological healthcare. 

The above information is a part of company’s filings submitted to BSE.

Tejnaksh Healthcare Share Price

15.98 0.25 (1.59%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7189.25
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1916.45
Aster DM Healthcare 635.10
Global Health 1163.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×